Journal of Diabetes Research / 2019 / Article / Tab 4

Research Article

Predictors of Effectiveness of Glucagon-Like Peptide-1 Receptor Agonist Therapy in Patients with Type 2 Diabetes and Obesity

Table 4

Dynamics of body mass index and glycosylated haemoglobin in exenatide and liraglutide groups.

TherapyBMI at baselineBMI after 24 weeksBMI reductionMean reduction of initial (%)HbA1c at baselineHbA1c after 24 weeksHbA1c reductionMean reduction of initial (%)

Exenatide, 42.840.62.25.48.87.81.01.2
Liraglutide, 40.137.62.54.08.37.21.10.9
-level0.2560.403